Other case reports describe singular cases of association of G-CSF use with myeloma infiltration of muscle, leukaemic nodules or pronounced lymphadenopathy at G-CSF injection site, marked progression of myeloma and transformation of aleukaemic leukaemia to leukaemia [32–36]. This evidence concerns the gene CSF3 and plasma cell myeloma.